IL-12 R beta 1

IL-12 R beta 1

IL-12 R beta 1 詳細

Molecule Name
Interleukin-12 receptor
分子の別称
IL-12 R beta 1,IL12RB1,CD212,IL12R,IL12RB,IL-12RB1
Drug Development Progress
治験薬の数9
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
Receptors, Interleukin-12
バックグランド
The human IL-12 R subunit is a member of the cytokine receptor superfamily and the functional high-affinity IL-12R is composed of at least two beta-type cytokine receptor subunits, each independently exhibiting a low affinity for IL-12. IL-12 R beta 1 (Interleukin-12 receptor subunit beta-1) is also known as IL-12RB1, CD212. Functions as an interleukin receptor which binds interleukin-12 with low affinity and is involved in IL12 transduction. Associated with IL12RB2 it forms a functional, high affinity receptor for IL12. Associates also with IL23R to form the interleukin-23 receptor which functions in IL23 signal transduction probably through activation of the Jak-Stat signaling cascade.

IL-12 R beta 1 製品リスト

Species
  • Human(4)
  • Cynomolgus(2)
  • Mouse(1)
Tag
  • His Tag & Avi Tag(3)
  • Fc Tag(2)
  • Fc Tag & Avi Tag(1)
  • His Tag(1)
Host
  • HEK293(7)
Conjugate
  • Biotin-labeled(4)
  • Unconjugated(3)
Grade
  • RUO(7)
Low Endotoxin
  • No(7)
You Have Viewed 1-7 Of 7 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
KLT-1101KLT-1101Phase 2 ClinicalKang Litai Pharmaceutical Co Ltd
Leukopenia; Melanoma; Sarcoma, Kaposi; Solid tumours; Thrombocytopenia
詳細
Edodekin alfaRO 247472; YM 01CPhase 2 ClinicalF. Hoffmann-La Roche Ltd, Valeant, Wistar Institute
Abdominal Neoplasms; Asthma; Bacterial Infections; Breast Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Graft vs Host Disease; Hepatitis B; Hepatitis C; HIV Infections; Leishmaniasis; Lymphoma; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Malaria; Melanoma; Neoplasms; Sarcoma, Kaposi; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
RTX-224RTX-224Phase 2 ClinicalRubius Therapeutics Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Skin Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms
詳細
KB-707KB707; KB-707Phase 2 ClinicalKrystal Biotech Inc
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Melanoma; Neoplasms; Skin Melanoma; Solid tumours
詳細
ASP-9801ASP-9801Phase 1 ClinicalAstellas Pharma Inc
Neoplasm Metastasis; Neoplasms; Solid tumours
詳細
Tolododekin AlfaANK101; ANK-101Phase 1 ClinicalAnkyra Therapeutics Inc
Carcinoma, Basosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Rejection of renal transplantation; Skin Neoplasms; Soft Tissue Injuries; Solid tumours
詳細
CLN-617CLN-617Phase 1 ClinicalCullinan Therapeutics Inc
Solid tumours
詳細
SON-1010SON-1010Phase 1 ClinicalSonnet Biotherapeutics Inc
Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Sarcoma; Solid tumours
詳細
phIL12 GETPhase 1 ClinicalInstitute Of Oncology Ljubljana
Carcinoma, Basal Cell
詳細
Customer Reviews
  • K***n2024-10-05
    I’ve been using the IL12 receptor protein from Acro Biosystem in my antibody discovery research, and I’m highly satisfied with its quality. The protein exhibits excellent stability and bioactivity, which has been crucial in my experiments targeting immune responses. It’s been a reliable reagent, showing consistent results across various assays. I highly recommend this product for anyone involved in immunological research, particularly in therapeutic antibody development.